ASPERGILLOSIS IGM ANTIBODIES

The Aspergillosis IgM Antibodies test detects IgM class antibodies directed against Aspergillus species in a patient’s blood, indicating recent or acute immune response to Aspergillus exposure. It is a serological assay performed on a venous blood sample and is used to support clinical suspicion of recent infection or exposure, particularly when combined with clinical assessment, imaging, or microbiological tests.

This home blood testing option in Dubai provides a convenient route to obtain timely results—typically delivered within 24–72 hours depending on the laboratory—helping clinicians decide on early management or further diagnostic steps. Note that IgM testing may have limitations (false negatives in immunocompromised patients or cross-reactivity with other fungi); results should be interpreted by a healthcare professional in the UAE and, where needed, corroborated with culture, PCR, or radiology.

• Aspergillus IgM Antibodies
• Aspergillus fumigatus IgM
• Antibody titre (AU/mL)
• Qualitative result (Reactive / Non-reactive)

• New or worsening respiratory symptoms with suspected fungal cause
• Febrile illness in immunocompromised or post-transplant patients
• Persistent cough, haemoptysis, or unexplained pulmonary infiltrates
• Recent significant exposure to mouldy environments or occupational risk
• To support differential diagnosis when imaging suggests fungal involvement

• Early detection of recent Aspergillus exposure to guide prompt care
• Convenient home blood collection by trained phlebotomists in Dubai
• Rapid laboratory processing with secure digital reporting
• Reduces need for immediate hospital visits and aids timely clinical decisions

• Venous blood sample collection at home by a certified phlebotomist
• No fasting required unless otherwise instructed by your clinician
• Inform provider of current antifungal, antibiotic, or immunosuppressive medications
• Patient identification (Emirates ID) and consent required for home collection